150 related articles for article (PubMed ID: 20197483)
1. Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
Campregher C; Honeder C; Chung H; Carethers JM; Gasche C
Clin Cancer Res; 2010 Mar; 16(6):1950-6. PubMed ID: 20197483
[TBL] [Abstract][Full Text] [Related]
2. Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair.
Chung H; Lopez CG; Holmstrom J; Young DJ; Lai JF; Ream-Robinson D; Carethers JM
Hum Mol Genet; 2010 Jul; 19(13):2638-47. PubMed ID: 20418486
[TBL] [Abstract][Full Text] [Related]
3. Mesalazine improves replication fidelity in cultured colorectal cells.
Gasche C; Goel A; Natarajan L; Boland CR
Cancer Res; 2005 May; 65(10):3993-7. PubMed ID: 15899787
[TBL] [Abstract][Full Text] [Related]
4. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
[TBL] [Abstract][Full Text] [Related]
5. The nucleotide composition of microsatellites impacts both replication fidelity and mismatch repair in human colorectal cells.
Campregher C; Scharl T; Nemeth M; Honeder C; Jascur T; Boland CR; Gasche C
Hum Mol Genet; 2010 Jul; 19(13):2648-57. PubMed ID: 20421367
[TBL] [Abstract][Full Text] [Related]
6. Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2).
Chung H; Chaudhry J; Lai JF; Young DJ; Carethers JM
Mutat Res; 2012 Jan; 729(1-2):73-80. PubMed ID: 22001236
[TBL] [Abstract][Full Text] [Related]
7. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
[TBL] [Abstract][Full Text] [Related]
8. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
[TBL] [Abstract][Full Text] [Related]
9. 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.
Luciani MG; Campregher C; Fortune JM; Kunkel TA; Gasche C
Gastroenterology; 2007 Jan; 132(1):221-35. PubMed ID: 17241873
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.
Tougeron D; Fauquembergue E; Rouquette A; Le Pessot F; Sesboüé R; Laurent M; Berthet P; Mauillon J; Di Fiore F; Sabourin JC; Michel P; Tosi M; Frébourg T; Latouche JB
Mod Pathol; 2009 Sep; 22(9):1186-95. PubMed ID: 19503063
[TBL] [Abstract][Full Text] [Related]
11. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
[TBL] [Abstract][Full Text] [Related]
12. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
Raeker MÖ; Pierre-Charles J; Carethers JM
Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
[TBL] [Abstract][Full Text] [Related]
13. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.
Lee J; Ballikaya S; Schönig K; Ball CR; Glimm H; Kopitz J; Gebert J
PLoS One; 2013; 8(2):e57074. PubMed ID: 23468914
[TBL] [Abstract][Full Text] [Related]
15. Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.
Kortüm B; Campregher C; Lang M; Khare V; Pinter M; Evstatiev R; Schmid G; Mittlböck M; Scharl T; Kucherlapati MH; Edelmann W; Gasche C
Gut; 2015 Dec; 64(12):1905-12. PubMed ID: 25429050
[TBL] [Abstract][Full Text] [Related]
16. The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.
Campregher C; Luciani MG; Biesenbach P; Evstatiev R; Lyakhovich A; Gasche C
Inflamm Bowel Dis; 2010 Apr; 16(4):576-82. PubMed ID: 19821510
[TBL] [Abstract][Full Text] [Related]
17. Identification of frame-shift intermediate mutant cells.
Gasche C; Chang CL; Natarajan L; Goel A; Rhees J; Young DJ; Arnold CN; Boland CR
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1914-9. PubMed ID: 12578960
[TBL] [Abstract][Full Text] [Related]
18. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.
Jung B; Smith EJ; Doctolero RT; Gervaz P; Alonso JC; Miyai K; Keku T; Sandler RS; Carethers JM
Int J Cancer; 2006 May; 118(10):2509-13. PubMed ID: 16380996
[TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas.
Samowitz WS; Slattery ML
Am J Pathol; 1997 Jul; 151(1):33-5. PubMed ID: 9212728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
